Rande Is . . . HOME Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Rande Is . . . HOME

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Miz who wrote (22228)	3/14/2000 2:10:00 PM
From: Tradelite	Read Replies (3) of 57584

Biotech selloff was predictable, once news came out over the past several days about how the government's top health officials and the biotech genome research companies don't agree on patenting of research data. President Clinton's statement today to that effect was the real sinker for the market. The government, of course, wants the data shared and can't allow private ownership of factual data....the biotech companies want to protect their investors who sunk millions of dollars into the research. So far, it's a standoff, from what I've read. I posted a story link here over the weekend that mentioned CRA (Celera) wanting to patent its findings and technology so it could license it to drug companies (Pfizer was mentioned.) The story also covered Celera's differences of opinion with the National Institutes of Health on patents. My opinion....the drug companies should soar today although they're not....once they get their hands on the genome research, there is no end to what they can accomplish. And if the government won't allow patents, that's all the better for the drug companies, if you ask me, but some might disagree on that point.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next